These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31520998)

  • 1. Burkitt-like lymphoma in a pediatric patient with familial adenomatous polyposis.
    Strobel KM; Crane JN; Bradford KL; Naeini Y; May WA; Chang VY
    Cancer Genet; 2019 Nov; 239():33-35. PubMed ID: 31520998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.
    Rymkiewicz G; Grygalewicz B; Chechlinska M; Blachnio K; Bystydzienski Z; Romejko-Jarosinska J; Woroniecka R; Zajdel M; Domanska-Czyz K; Martin-Garcia D; Nadeu F; Swoboda P; Rygier J; Pienkowska-Grela B; Siwicki JK; Prochorec-Sobieszek M; Salaverria I; Siebert R; Walewski J
    Mod Pathol; 2018 May; 31(5):732-743. PubMed ID: 29327714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS.
    Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Borkowska K; Kotyl A; Blachnio K; Bystydzienski Z; Nowakowska B; Pienkowska-Grela B
    Am J Clin Pathol; 2017 Dec; 149(1):17-28. PubMed ID: 29272887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma.
    Gebauer N; Witte HM; Merz H; Oschlies I; Klapper W; Caliebe A; Tharun L; Spielmann M; von Bubnoff N; Feller AC; Murga Penas EM
    Blood Adv; 2021 Dec; 5(23):5220-5225. PubMed ID: 34500469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
    Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
    Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological and molecular genetic features of Burkitt-like lymphoma with 11q aberration].
    Zhang YP; Zhang L; Zhang DD; Wang GN; Zhao WG; Jian XY; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2021 Jun; 50(6):604-608. PubMed ID: 34078047
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of 2016 WHO classification in the diagnosis of paediatric high-grade
    Zhang L; Brown LE; Bowen LM; McCarthy LC; Cooley LD; Repnikova E; Gener MA; Garola R; August KJ; Hays JA; Zwick DL; Li W
    J Clin Pathol; 2020 Sep; 73(9):563-570. PubMed ID: 31964683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic progression of post-transplant Burkitt-like lymphoma case with 11q-Gain/Loss and MYC amplification.
    Grygalewicz B; Woroniecka R; Rymkiewicz G; Rygier J; Malawska N; Blachnio K; Bystydzienski Z; Borysiuk A; Nowakowska B; Pienkowska-Grela B
    Cancer Genet; 2020 Jul; 245():1-5. PubMed ID: 32531723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.
    Gonzalez-Farre B; Ramis-Zaldivar JE; Salmeron-Villalobos J; Balagué O; Celis V; Verdu-Amoros J; Nadeu F; Sábado C; Ferrández A; Garrido M; García-Bragado F; de la Maya MD; Vagace JM; Panizo CM; Astigarraga I; Andrés M; Jaffe ES; Campo E; Salaverria I
    Haematologica; 2019 Sep; 104(9):1822-1829. PubMed ID: 30733272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group.
    Au-Yeung RKH; Arias Padilla L; Zimmermann M; Oschlies I; Siebert R; Woessmann W; Burkhardt B; Klapper W
    Br J Haematol; 2020 Sep; 190(5):753-763. PubMed ID: 32239695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinicopathologic characteristics of Burkitt-like lymphoma with chromosome 11q aberration].
    Wei P; Zhang YL; Xie JL; Zheng YY; Liu W; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):176-179. PubMed ID: 29534356
    [No Abstract]   [Full Text] [Related]  

  • 12. Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.
    Septer S; Lawson CE; Anant S; Attard T
    Fam Cancer; 2016 Jul; 15(3):477-85. PubMed ID: 27056662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis.
    Park J; Kim JW; Park H; Park SY; Kim TH; Kim SW; Oh YL; Chung JH
    Thyroid; 2019 Nov; 29(11):1606-1614. PubMed ID: 31469036
    [No Abstract]   [Full Text] [Related]  

  • 14. Upper gastrointestinal polyps in familial adenomatous polyposis.
    Offerhaus GJ; Entius MM; Giardiello FM
    Hepatogastroenterology; 1999; 46(26):667-9. PubMed ID: 10370594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A distinct variant of papillary thyroid carcinoma indicating familial adenomatous polyposis (FAP): a case report and brief review.
    Liyanapathirana N; Seneviratne SA; Samarasekera DN
    BMC Res Notes; 2015 Dec; 8():795. PubMed ID: 26681171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge of the adenomatous polyposis coli gene and its clinical application.
    Petersen GM
    Ann Med; 1994 Jun; 26(3):205-8. PubMed ID: 8074838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The presymptomatic molecular diagnosis of familial adenomatous polyposis in Singapore.
    Khine K; Smith DR; Law HY; Goh HS
    Singapore Med J; 1995 Oct; 36(5):521-4. PubMed ID: 8882539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revolutionary advances in the diagnosis and treatment of Familial Adenomatous Polyposis.
    Edlich R; Cross CL; Wack CA; Chase ME; Gubler K; Long WB
    J Environ Pathol Toxicol Oncol; 2009; 28(1):47-52. PubMed ID: 19392654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pathogenic large germline deletion in adenomatous polyposis coli gene in a Chinese family with familial adenomatous polyposis.
    Zhang Z; Liang S; Huang H; Wang D; Zhang X; Wu J; Chen H; Wang Y; Rong T; Zhou Y; Banerjee S
    Oncotarget; 2016 Aug; 7(31):50392-50400. PubMed ID: 27391059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital hypertrophy of the retinal pigment epithelium serves as a clinical marker in a family with familial adenomatous polyposis.
    Parisi ML
    J Am Optom Assoc; 1995 Feb; 66(2):106-12. PubMed ID: 7714311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.